GCK and HNF1A Mutations in Canadian Families With Maturity Onset Diabetes of the Young (MODY)

被引:17
作者
Cao, Henian [1 ]
Shorey, Sanam [1 ]
Robinson, John [1 ]
Metzger, Daniel L. [2 ]
Stewart, Laura [2 ]
Cummings, Elizabeth [3 ]
Hegele, Robert A. [1 ]
机构
[1] Robarts Res Inst, London, ON N6A 5K8, Canada
[2] British Columbia Childrens Hosp, Vancouver, BC V6H 3V4, Canada
[3] IWK Hlth Ctr, Halifax, NS, Canada
关键词
carbohydrate; diabetes; GCK; HNF1A; insulin; metabolism; MODY; monogenic diseases; transcription factors;
D O I
10.1002/humu.9090
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Maturity onset diabetes of the young (MODY) is a genetically heterogeneous form of type 2 diabetes that is characterized by autosomal dominant inheritance, onset in early adulthood and a primary defect in insulin secretion. Mutations in at least six genes have been shown to underlie MODY, including mutations in GCK (encoding glucokinase, also called MODY2) and mutations in HNF1A (encoding hepatocyte nuclear factor-1 alpha, also called MODY3). We sequenced genomic DNA from probands of seven Canadian MODY families. In four probands, we detected four novel GCK mutations, namely IVS2-7G>A, G72R, T206R and S263P. In three other probands, we detected three HNF1A mutations, of which two were novel, namely 1051delCA and Q250X, and one had been previously reported, namely R131Q. The novel mutations expand the spectrum of MODY mutations. In addition, knowledge of the specific defect can be used to pre-symptomatically identify family members at risk for developing MODY. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:478 / 479
页数:3
相关论文
共 13 条
[1]  
Appleton M., 1997, Diabetologia, V40, pA161
[2]   Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
LANCET, 2002, 359 (9323) :2072-2077
[3]   SCOPE AND HETEROGENEOUS NATURE OF MODY [J].
FAJANS, SS .
DIABETES CARE, 1990, 13 (01) :49-64
[4]   Mechanisms of disease: Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. [J].
Fajans, SS ;
Bell, GI ;
Polonsky, KS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (13) :971-980
[5]   The hepatic nuclear factor-1α G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree [J].
Hegele, RA ;
Cao, HI ;
Harris, SB ;
Hanley, AJG ;
Zinman, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (03) :1077-1082
[6]   Structural model of human glucokinase in complex with glucose and ATP - Implications for the mutants that cause hypo- and hyperglycemia [J].
Mahalingam, B ;
Cuesta-Munoz, A ;
Davis, EA ;
Matschinsky, FM ;
Harrison, RW ;
Weber, IT .
DIABETES, 1999, 48 (09) :1698-1705
[7]  
McCarthy M I, 2001, Expert Rev Mol Diagn, V1, P403, DOI 10.1586/14737159.1.4.403
[8]   CLINICAL CHARACTERISTICS OF SUBJECTS WITH A MISSENSE MUTATION IN GLUCOKINASE [J].
PAGE, RCL ;
HATTERSLEY, AT ;
LEVY, JC ;
BARROW, B ;
PATEL, P ;
LO, D ;
WAINSCOAT, JS ;
PERMUTT, MA ;
BELL, GI ;
TURNER, RC .
DIABETIC MEDICINE, 1995, 12 (03) :209-217
[9]   HNF-1α G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community [J].
Triggs-Raine, BL ;
Kirkpatrick, RD ;
Kelly, SL ;
Norquay, LD ;
Cattini, PA ;
Yamagata, K ;
Hanley, AJG ;
Zinman, B ;
Harris, SB ;
Barrett, PH ;
Hegele, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (07) :4614-4619
[10]   HNF1, A HOMEOPROTEIN MEMBER OF THE HEPATIC TRANSCRIPTION REGULATORY NETWORK [J].
TRONCHE, F ;
YANIV, M .
BIOESSAYS, 1992, 14 (09) :579-587